Open AccessWeek 96 results of a phase 3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients
Author(s) -
C. Orkin,
Julian Eron,
J. Rockstroh,
D. Podzamczer,
S. Esser,
L. Vandekerckhove,
E. Van Landuyt,
E. Lathouwers,
V. Hufkens,
J. Jezorwski,
M. Opsomer,
AMBER study group
Publication year - 2020
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/vxxw-nd48
Subject(s) - cobicistat , tenofovir alafenamide , darunavir , emtricitabine , human immunodeficiency virus (hiv) , medicine , virology , antiretroviral therapy , viral load